Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Barry Shin is CFO at Compass Therapeutics. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jan 5, 2026, each linked to the official Form 4.
CFO
Disclosures on record
2
Companies involved
1
As of the latest filing on , Barry Shin reported holding 525,000 shares of Compass Therapeutics (CMPX), worth about $319K at the last close of $1 (Nov 17, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Compass Therapeutics CMPX | 525,000 | 525K direct | $1 | $319K | Jan 2, 2026 |
Is this Barry Shin’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Compass TherapeuticsCMPX
2 disclosures · Jan 2026
Jan 2, 2026125Kdisclosed Jan 5
DetailsOfficial recordJan 2, 2026670Kdisclosed Jan 5
DetailsOfficial recordOn the latest SEC Form 4, dated Jan 2, 2026, Barry Shin reported holding 525,000 shares of Compass Therapeutics (CMPX). At the last close of $1 on Nov 17, 2026, that is about $319K. This is the stake disclosed in filings, not a net worth.